Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tumor protein p53 binding protein 1 | Starlite/ChEMBL | References |
Homo sapiens | PHD finger protein 23 | Starlite/ChEMBL | References |
Homo sapiens | lysine (K)-specific demethylase 5A | Starlite/ChEMBL | References |
Homo sapiens | ubiquitin-like with PHD and ring finger domains 1 | Starlite/ChEMBL | References |
Homo sapiens | mbt domain containing 1 | Starlite/ChEMBL | References |
Homo sapiens | l(3)mbt-like 3 (Drosophila) | Starlite/ChEMBL | References |
Homo sapiens | chromobox homolog 7 | Starlite/ChEMBL | References |
Homo sapiens | l(3)mbt-like 4 (Drosophila) | Starlite/ChEMBL | References |
Homo sapiens | l(3)mbt-like 1 (Drosophila) | Starlite/ChEMBL | References |
Homo sapiens | Scm-like with four mbt domains 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0628 | 0.5988 | 0.6951 |
Plasmodium vivax | protein kinase, putative | 0.003 | 0.003 | 0.349 |
Schistosoma mansoni | hypothetical protein | 0.0186 | 0.1585 | 0.156 |
Loa Loa (eye worm) | hypothetical protein | 0.0115 | 0.0873 | 0.1684 |
Echinococcus granulosus | lamin | 0.0058 | 0.0312 | 0.0504 |
Loa Loa (eye worm) | hypothetical protein | 0.0057 | 0.0301 | 0.0581 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0115 | 0.0873 | 0.0845 |
Echinococcus multilocularis | Sterile alpha motif type | 0.003 | 0.003 | 0.0023 |
Trichomonas vaginalis | cgi-62, putative | 0.003 | 0.003 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0055 | 0.0276 | 0.0521 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0547 | 0.5183 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.0058 | 0.0312 | 0.0504 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0115 | 0.0873 | 0.1442 |
Echinococcus multilocularis | sterile alpha and tir motif containing protein | 0.003 | 0.003 | 0.0023 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0318 | 0.2899 | 0.2878 |
Echinococcus granulosus | liprin alpha 2 | 0.003 | 0.003 | 0.0033 |
Echinococcus granulosus | Sterile alpha motif SAM | 0.003 | 0.003 | 0.0033 |
Echinococcus granulosus | SAM and MBT domain containing protein | 0.0461 | 0.432 | 0.7209 |
Echinococcus multilocularis | Sterile alpha motif SAM | 0.003 | 0.003 | 0.0023 |
Echinococcus granulosus | liprin alpha 2 | 0.003 | 0.003 | 0.0033 |
Echinococcus multilocularis | SAM and MBT domain containing protein | 0.0461 | 0.432 | 0.5011 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0628 | 0.5988 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0055 | 0.0276 | 0.0521 |
Brugia malayi | mbt repeat family protein | 0.0547 | 0.5183 | 1 |
Echinococcus granulosus | polyhomeotic protein 2 | 0.003 | 0.003 | 0.0033 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.003 | 0.0059 |
Echinococcus multilocularis | polyhomeotic protein 2 | 0.003 | 0.003 | 0.0023 |
Echinococcus multilocularis | lamin | 0.0058 | 0.0312 | 0.035 |
Echinococcus multilocularis | geminin | 0.0186 | 0.1585 | 0.1831 |
Echinococcus multilocularis | polycomb protein SCMH1 | 0.0318 | 0.2899 | 0.3359 |
Leishmania major | hypothetical protein, conserved | 0.0028 | 0.0006 | 0.5 |
Echinococcus multilocularis | tumor suppressor p53 binding protein 1 | 0.0392 | 0.3633 | 0.4212 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0164 | 0.1364 | 0.2631 |
Schistosoma mansoni | intermediate filament proteins | 0.0058 | 0.0312 | 0.0282 |
Brugia malayi | cytoplasmic intermediate filament protein | 0.0031 | 0.0042 | 0.0069 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.003 | 0.0059 |
Brugia malayi | Sphingomyelin synthase-related 1 | 0.003 | 0.003 | 0.0048 |
Echinococcus multilocularis | chromobox protein 2 | 0.0236 | 0.208 | 0.2407 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0111 | 0.084 | 0.1387 |
Schistosoma mansoni | phd finger protein | 0.0049 | 0.0216 | 0.0186 |
Echinococcus granulosus | chromobox protein 2 | 0.0236 | 0.208 | 0.3463 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0093 | 0.0654 | 0.0749 |
Schistosoma mansoni | chromobox protein | 0.0236 | 0.208 | 0.2056 |
Brugia malayi | intermediate filament protein | 0.0058 | 0.0312 | 0.0591 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0892 | 0.861 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0186 | 0.1585 | 0.156 |
Echinococcus granulosus | lamin dm0 | 0.0058 | 0.0312 | 0.0504 |
Toxoplasma gondii | histone lysine demethylase JMJC1/KDM5D/JARID1D | 0.0039 | 0.0116 | 0.4434 |
Echinococcus multilocularis | musashi | 0.0058 | 0.0312 | 0.035 |
Echinococcus granulosus | polycomb protein SCMH1 | 0.0318 | 0.2899 | 0.4832 |
Echinococcus multilocularis | histone acetyltransferase myst3 | 0.0049 | 0.0216 | 0.0238 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0055 | 0.0276 | 0.0532 |
Toxoplasma gondii | PLU-1 family protein | 0.0053 | 0.0254 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0312 | 0.0602 |
Loa Loa (eye worm) | tnks protein | 0.003 | 0.003 | 0.0059 |
Echinococcus granulosus | histone acetyltransferase myst3 | 0.0049 | 0.0216 | 0.0343 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.003 | 0.0059 |
Loa Loa (eye worm) | toll and interleukin 1 receptor domain-containing protein isoform f | 0.003 | 0.003 | 0.0059 |
Loa Loa (eye worm) | hypothetical protein | 0.0547 | 0.5183 | 1 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0115 | 0.0873 | 0.1003 |
Trypanosoma brucei | Present in the outer mitochondrial membrane proteome 24 | 0.003 | 0.003 | 1 |
Echinococcus granulosus | polyhomeotic proximal chromatin protein | 0.003 | 0.003 | 0.0033 |
Echinococcus granulosus | Sterile alpha motif type | 0.003 | 0.003 | 0.0033 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0103 | 0.0199 |
Echinococcus granulosus | chromodomain helicase DNA binding protein 4 | 0.0032 | 0.0052 | 0.0069 |
Brugia malayi | jmjC domain containing protein | 0.003 | 0.0033 | 0.0052 |
Brugia malayi | AIDA-1b | 0.003 | 0.003 | 0.0048 |
Schistosoma mansoni | chromodomain helicase DNA binding protein | 0.0032 | 0.0052 | 0.0022 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0058 | 0.0312 | 0.0602 |
Echinococcus granulosus | Jumonji AT rich interactive domain 1B | 0.0137 | 0.1091 | 0.1807 |
Brugia malayi | Shank2E | 0.003 | 0.003 | 0.0048 |
Trypanosoma cruzi | Kinesin-13 5, putative | 0.003 | 0.003 | 1 |
Brugia malayi | hypothetical protein | 0.003 | 0.003 | 0.0048 |
Echinococcus multilocularis | chromodomain helicase DNA binding protein 4 | 0.0032 | 0.0052 | 0.0048 |
Brugia malayi | hypothetical protein | 0.003 | 0.003 | 0.0048 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0103 | 0.0073 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0006 | 0.0011 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.003 | 0.0059 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0115 | 0.0873 | 0.1675 |
Trypanosoma brucei | SAM domain (Sterile alpha motif), putative | 0.003 | 0.003 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.003 | 0.003 | 0.5 |
Echinococcus multilocularis | Jumonji, AT rich interactive domain 1B | 0.0137 | 0.1091 | 0.1256 |
Onchocerca volvulus | 0.0058 | 0.0312 | 0.0546 | |
Echinococcus granulosus | sphingomyelin synthase protein 1 | 0.003 | 0.003 | 0.0033 |
Brugia malayi | mbt repeat family protein | 0.0331 | 0.3028 | 0.5838 |
Echinococcus granulosus | pdz domain containing protein | 0.003 | 0.003 | 0.0033 |
Plasmodium vivax | JmjC domain containing protein | 0.0035 | 0.0077 | 1 |
Schistosoma mansoni | lamin | 0.0058 | 0.0312 | 0.0282 |
Schistosoma mansoni | lamin | 0.0058 | 0.0312 | 0.0282 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0037 | 0.0103 | 0.0188 |
Loa Loa (eye worm) | intermediate filament protein | 0.0058 | 0.0312 | 0.0602 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0115 | 0.0873 | 0.1442 |
Echinococcus multilocularis | liprin alpha 2 | 0.003 | 0.003 | 0.0023 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0011 | 0.0021 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.003 | 0.0059 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0058 | 0.0312 | 0.0591 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0318 | 0.2899 | 0.2878 |
Echinococcus multilocularis | liprin alpha 2 | 0.003 | 0.003 | 0.0023 |
Brugia malayi | sterile alpha and TIR motif containing protein 1 isoform a | 0.003 | 0.003 | 0.0048 |
Schistosoma mansoni | scm-relatedprotein containing 4 mbt domains (sfmbt) | 0.0461 | 0.432 | 0.4303 |
Toxoplasma gondii | hypothetical protein | 0.0031 | 0.0035 | 0.1173 |
Schistosoma mansoni | jumonji domain containing protein | 0.003 | 0.0033 | 0.0002 |
Echinococcus multilocularis | pdz domain containing protein | 0.003 | 0.003 | 0.0023 |
Plasmodium falciparum | JmjC domain-containing protein, putative | 0.0035 | 0.0077 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0111 | 0.084 | 0.0812 |
Brugia malayi | bicaudal-C | 0.003 | 0.003 | 0.0048 |
Echinococcus multilocularis | lamin dm0 | 0.0058 | 0.0312 | 0.035 |
Brugia malayi | jmjC domain containing protein | 0.0164 | 0.1364 | 0.2623 |
Brugia malayi | CHD4 protein | 0.0032 | 0.0052 | 0.0089 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.003 | 0.0059 |
Trichomonas vaginalis | c2h2 zinc finger protein, putative | 0.003 | 0.003 | 0.5 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0115 | 0.0873 | 0.1003 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.003 | 0.0059 |
Schistosoma mansoni | hypothetical protein | 0.0392 | 0.3633 | 0.3614 |
Brugia malayi | Liprin-alpha 2 | 0.003 | 0.003 | 0.0048 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.003 | 0.0033 | 0.0037 |
Brugia malayi | cask-interacting protein 2 | 0.003 | 0.003 | 0.0048 |
Trypanosoma cruzi | hypothetical protein | 0.003 | 0.003 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0111 | 0.084 | 0.0812 |
Brugia malayi | coiled-coil like protein 1 | 0.003 | 0.003 | 0.0048 |
Onchocerca volvulus | 0.0361 | 0.3329 | 0.6402 | |
Giardia lamblia | Kinesin-13 | 0.003 | 0.003 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.003 | 0.0059 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0276 | 0.0532 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0031 | 0.0042 | 0.008 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.003 | 0.0033 | 0.0026 |
Echinococcus multilocularis | polyhomeotic proximal chromatin protein | 0.003 | 0.003 | 0.0023 |
Echinococcus granulosus | tumor suppressor p53 binding protein 1 | 0.0392 | 0.3633 | 0.606 |
Loa Loa (eye worm) | mbt repeat family protein | 0.0331 | 0.3028 | 0.5843 |
Echinococcus multilocularis | sphingomyelin synthase protein 1 | 0.003 | 0.003 | 0.0023 |
Echinococcus granulosus | geminin | 0.0186 | 0.1585 | 0.2635 |
Loa Loa (eye worm) | AIDA-1b | 0.003 | 0.003 | 0.0059 |
Trypanosoma cruzi | Kinesin-13 5, putative | 0.003 | 0.003 | 1 |
Loa Loa (eye worm) | MBCTL1 | 0.0115 | 0.0873 | 0.1684 |
Giardia lamblia | Giardia trophozoite antigen GTA-1 | 0.003 | 0.003 | 0.5 |
Onchocerca volvulus | 0.0058 | 0.0312 | 0.0546 | |
Loa Loa (eye worm) | CHromoDomain protein family member | 0.0032 | 0.0052 | 0.01 |
Echinococcus granulosus | sterile alpha and tir motif containing protein | 0.003 | 0.003 | 0.0033 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | = 55 % | Inhibition of GST-fused L3MBTL1 3xMBT domain (unknown origin) expressed in Escherichia coli BL21 (DE3) pLysS cells/biotinylated H4K20Me1 peptide interaction assessed as binding of L3MBT1 repeats to H4K20Me1 at 25 uM by pull-down assay based western blot analysis | ChEMBL. | No reference |
Activity (binding) | = 79 % | Inhibition of GST-fused L3MBTL1 3xMBT domain (unknown origin) expressed in Escherichia coli BL21 (DE3) pLysS cells/biotinylated H4K20Me1 peptide interaction assessed as binding of L3MBT1 repeats to H4K20Me1 at 5 uM by pull-down assay based western blot analysis | ChEMBL. | No reference |
Activity (binding) | = 94 % | Inhibition of GST-fused L3MBTL1 3xMBT domain (unknown origin) expressed in Escherichia coli BL21 (DE3) pLysS cells/biotinylated H4K20Me1 peptide interaction assessed as binding of L3MBT1 repeats to H4K20Me1 at 1 uM by pull-down assay based western blot analysis | ChEMBL. | No reference |
IC50 (binding) | Binding affinity to CBX7 by chemiluminescent assay | ChEMBL. | 21417280 | |
IC50 (binding) | Binding affinity to human SFMBT by chemiluminescent assay | ChEMBL. | 21417280 | |
IC50 (binding) | Binding affinity to MBTD1 by chemiluminescent assay | ChEMBL. | 21417280 | |
IC50 (binding) | Binding affinity to PHF13 by chemiluminescent assay | ChEMBL. | 21417280 | |
IC50 (binding) | = 2.8 uM | Inhibition of His-tagged L3MBTL3 (unknown origin) using H4K20Me2 as substrate incubated for 30 mins at room temperature followed by incubation under dark condition for 30 mins by AlphaScreen assay | ChEMBL. | 24466405 |
IC50 (binding) | = 3.1 uM | Inhibition of L3MBTL3 (unknown origin) after 30 mins by AlphaScreen assay | ChEMBL. | 24040942 |
IC50 (binding) | = 4.2 uM | Inhibition of L3MBTL1 (unknown origin) after 30 mins by AlphaScreen assay | ChEMBL. | 24040942 |
IC50 (binding) | = 4.7 uM | Inhibition of L3MBTL3 (unknown origin) using H4K20me2 as substrate after 30 mins by LNCE-TR-FRET assay | ChEMBL. | 24040942 |
IC50 (binding) | = 4.8 uM | Antagonist activity at His-tagged L3MBTL3 (unknown origin) assessed as inhibition of L3MBTL3/biotinylated H4K20Me2 peptide interaction after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
IC50 (binding) | = 6 uM | Binding affinity to human L3MBTL1 by chemiluminescent assay | ChEMBL. | 21417280 |
IC50 (binding) | = 7.9 uM | Antagonist activity at N-terminal His6-tagged L3MBTL1 (unknown origin) expressed in Escherichia coli BL21 Codon Plus RIL cells assessed as inhibition of L3MBTL1/biotinylated H4K20Me1 peptide interaction after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
IC50 (binding) | > 10 uM | Inhibition of SFMBT1 (unknown origin) after 30 mins by AlphaScreen assay | ChEMBL. | 24040942 |
IC50 (binding) | > 10 uM | Inhibition of L3MBTL4 (unknown origin) after 30 mins by AlphaScreen assay | ChEMBL. | 24040942 |
IC50 (binding) | > 10 uM | Inhibition of JARID1A (unknown origin) after 30 mins by AlphaScreen assay | ChEMBL. | 24040942 |
IC50 (binding) | > 10 uM | Inhibition of PHF23 (unknown origin) after 30 mins by AlphaScreen assay | ChEMBL. | 24040942 |
IC50 (binding) | > 10 uM | Inhibition of UHRF1 (unknown origin) after 30 mins by AlphaScreen assay | ChEMBL. | 24040942 |
IC50 (binding) | > 10 uM | Inhibition of 53BP1 (unknown origin) after 30 mins by AlphaScreen assay | ChEMBL. | 24040942 |
IC50 (binding) | > 10 uM | Inhibition of CBX7 (unknown origin) after 30 mins by AlphaScreen assay | ChEMBL. | 24040942 |
IC50 (binding) | > 10 uM | Inhibition of MBTD1 (unknown origin) after 30 mins by AlphaScreen assay | ChEMBL. | 24040942 |
IC50 (binding) | = 21 uM | Inhibition of His-tagged L3MBTL1 (unknown origin) using H4K20Me1 as substrate incubated for 30 mins at room temperature followed by incubation under dark condition for 30 mins by AlphaScreen assay | ChEMBL. | 24466405 |
IC50 (binding) | > 30 uM | Inhibition of GST-tagged PHF23 (unknown origin) using H3K4Me3 as substrate incubated for 30 mins at room temperature followed by incubation under dark condition for 30 mins by AlphaScreen assay | ChEMBL. | 24466405 |
IC50 (binding) | > 30 uM | Inhibition of GST-tagged Jarid1A (unknown origin) using H3K4Me3 as substrate incubated for 30 mins at room temperature followed by incubation under dark condition for 30 mins by AlphaScreen assay | ChEMBL. | 24466405 |
IC50 (binding) | > 30 uM | Inhibition of UHRF1 tandem tudor domain (121 to 286) (unknown origin) expressed in Escherichia coli BL21 Rosetta DE3 using H3K9Me3 as substrate incubated for 30 mins at room temperature followed by incubation under dark condition for 30 mins by AlphaScreen assay | ChEMBL. | 24466405 |
IC50 (binding) | > 30 uM | Inhibition of CBX7 (8 to 62) (unknown origin) expressed in Escherichia coli BL21 Rosetta DE3 using H3K9Me3 as substrate incubated for 30 mins at room temperature followed by incubation under dark condition for 30 mins by AlphaScreen assay | ChEMBL. | 24466405 |
IC50 (binding) | > 30 uM | Inhibition of 53BP1 (1485 to 1611) (unknown origin) expressed in Escherichia coli BL21 Rosetta DE3 using H4K20Me2 as substrate incubated for 30 mins at room temperature followed by incubation under dark condition for 30 mins by AlphaScreen assay | ChEMBL. | 24466405 |
IC50 (binding) | > 30 uM | Antagonist activity at L3MBTL4 (unknown origin) assessed as inhibition of L3MBTL4/biotinylated H2AK36Me1 peptide interaction after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
IC50 (binding) | > 30 uM | Antagonist activity at MBTD1 (unknown origin) assessed as inhibition of MBTD1/biotinylated H4K20Me1 peptide interaction after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
IC50 (binding) | > 30 uM | Antagonist activity at SFMBT1 (unknown origin) assessed as inhibition of SFMBT1/biotinylated H3K9Me1 peptide interaction after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
IC50 (binding) | > 30 uM | Antagonist activity at Flag-tagged CBX7 (unknown origin) assessed as inhibition of CBX7/biotinylated H3K9Me3 peptide interaction after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
IC50 (binding) | = 35 uM | Binding affinity to L3MBTL3 by chemiluminescent assay | ChEMBL. | 21417280 |
IC50 (binding) | = 69 uM | Binding affinity to L3MBTL4 by chemiluminescent assay | ChEMBL. | 21417280 |
IC50 (binding) | > 300 uM | Inhibition of MBTD1 (130 to 566) (unknown origin) expressed in Escherichia coli BL21 Rosetta DE3 using H4K20Me1 as substrate incubated for 30 mins at room temperature followed by incubation under dark condition for 30 mins by AlphaScreen assay | ChEMBL. | 24466405 |
Inhibition (binding) | Antagonist activity at SFMBT1 (unknown origin) assessed as inhibition of SFMBT1/biotinylated H3K9Me1 peptide interaction at 30 uM after 30 mins by AlphaScreen assay | ChEMBL. | No reference | |
Inhibition (binding) | Inhibition of GST-fused L3MBTL1 3xMBT domain (unknown origin) expressed in Escherichia coli BL21 (DE3) pLysS cells/biotinylated H4K20Me1 peptide interaction assessed as binding of L3MBT1 repeats to H4K20Me1 by pull-down assay based western blot analysis | ChEMBL. | No reference | |
Inhibition (binding) | = 9 % | Antagonist activity at Flag-tagged CBX7 (unknown origin) assessed as inhibition of CBX7/biotinylated H3K9Me3 peptide interaction at 30 uM after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
Inhibition (binding) | = 23 % | Antagonist activity at MBTD1 (unknown origin) assessed as inhibition of MBTD1/biotinylated H4K20Me1 peptide interaction at 30 uM after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
Inhibition (binding) | = 41 % | Antagonist activity at L3MBTL4 (unknown origin) assessed as inhibition of L3MBTL4/biotinylated H2AK36Me1 peptide interaction at 30 uM after 30 mins by AlphaScreen assay | ChEMBL. | No reference |
Kd (binding) | = 5 uM | Binding affinity to human L3MBTL1 assessed as dissociation constant by isothermal titration calorimetric assay | ChEMBL. | 21417280 |
Kd (binding) | = 8.6 uM | Binding affinity to L3MBTL1 (unknown origin) by isothermal titration calorimetry | ChEMBL. | No reference |
Kd (binding) | = 10 uM | Displacement of FAM-AHA-ARTKQTARK(Me)STGGKA-CO2H from human L3MBTL1 assessed as apparent dissociation constant after 20 mins by FP-displacement Assay | ChEMBL. | 21417280 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
3 literature references were collected for this gene.